Topic

Aetna (CVS Health)

A collection of 1080 issues

How to Get Poteligeo (mogamulizumab-kpkc) Approved by Aetna CVS Health in Washington: Complete Prior Authorization and Appeals Guide

Quick Answer: Getting Poteligeo Covered in Washington Poteligeo (mogamulizumab-kpkc) requires prior authorization from Aetna CVS Health for relapsed/refractory mycosis fungoides or Sézary syndrome after ≥1 prior systemic therapy. Your oncologist submits documentation via the Aetna provider portal showing confirmed CTCL diagnosis, prior treatment failures, and medical necessity. If denied,
7 min read

If Pombiliti Isn't Approved by Aetna (CVS Health) in New Jersey: Formulary Alternatives & Exception Paths

Answer Box If Aetna (CVS Health) denies Pombiliti (cipaglucosidase alfa-atga) in New Jersey, formulary alternatives include Lumizyme (alglucosidase alfa) and Nexviazyme (avalglucosidase alfa-ngpt) as preferred ERTs for late-onset Pompe disease. Request a formulary exception by documenting inadequate response to standard ERTs with objective measures (6-minute walk test, pulmonary function). After
5 min read